使用FAPI配体进行正电子发射断层显像（PET）成像诊断非肝硬化肝细胞癌 - Suppr

PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma.

作者信息

Lee Zhenghong, Lu Zheng-Rong, Sexton Sandra, Xin Wei

机构信息

Radiology, School of Medicine, Case Western Reserve University; Nuclear Medicine, Radiology, University Hospitals Cleveland Medical Center, 11100 Euclid Ave., Cleveland, OH, 44106, USA.

Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 44106, USA.

出版信息

Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3190-3191. doi: 10.1007/s00259-023-06324-y. Epub 2023 Jul 5.

DOI:10.1007/s00259-023-06324-y

PMID:37405467

Abstract

摘要

相似文献

PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma.

Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3190-3191. doi: 10.1007/s00259-023-06324-y. Epub 2023 Jul 5.

AlF-NOTA-FAPI-04 outperforms F-FDG PET/CT in imaging for intrahepatic metastasis of hepatocellular carcinoma.

Hell J Nucl Med. 2022 Sep-Dec;25(3):326-327. doi: 10.1967/s002449912527.

[ Ga]Ga-DOTA-FAPI-04 PET/CT imaging of cirrhosis with hepatocellular carcinoma.

Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1536-1537. doi: 10.1007/s00259-022-06077-0. Epub 2022 Dec 12.

FAPI PET Positivity in Fibrolamellar Hepatocellular Carcinoma.

Clin Nucl Med. 2023 Jul 1;48(7):e332-e333. doi: 10.1097/RLU.0000000000004661. Epub 2023 Apr 17.

Liver metastases from medullary thyroid carcinoma detected on Ga-FAPI-04 PET/CT.

Endocrine. 2021 Dec;74(3):727-728. doi: 10.1007/s12020-021-02800-3. Epub 2021 Jun 24.

Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [F]F-FDG PET/CT in Patients with Liver Malignancies.

Mol Imaging Biol. 2022 Oct;24(5):818-829. doi: 10.1007/s11307-022-01732-2. Epub 2022 Apr 29.

68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient.

Clin Nucl Med. 2020 Oct;45(10):e430-e432. doi: 10.1097/RLU.0000000000003015.

The Added Value of Contrast-Enhanced 68 Ga-FAPI-04 PET/MRI Over 18 F-FDG PET/CT in Hepatocellular Carcinoma.

Clin Nucl Med. 2024 Nov 1;49(11):1039-1040. doi: 10.1097/RLU.0000000000005342. Epub 2024 Jun 20.

Comparison of Baseline Ga-FAPI and F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib.

J Nucl Med. 2023 Oct;64(10):1532-1539. doi: 10.2967/jnumed.123.265712. Epub 2023 Jul 27.

[Ga]Ga-DOTA-FAPI-04 and [F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer.

Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2078-2079. doi: 10.1007/s00259-020-04847-2. Epub 2020 May 8.

引用本文的文献

Intriguing information from recent letter and article regarding unwanted targeting of salivary glands by PSMA ligands.

Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):2950-2951. doi: 10.1007/s00259-023-06325-x. Epub 2023 Jul 3.

本文引用的文献

PET Imaging of Hepatocellular Carcinoma Using ZD2-(Ga-NOTA).

J Hepatocell Carcinoma. 2023 Feb 22;10:291-301. doi: 10.2147/JHC.S390939. eCollection 2023.

[ Ga]Ga-DOTA-FAPI-04 PET/CT imaging of cirrhosis with hepatocellular carcinoma.

Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1536-1537. doi: 10.1007/s00259-022-06077-0. Epub 2022 Dec 12.

Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West.

PLoS One. 2021 Jan 13;16(1):e0244939. doi: 10.1371/journal.pone.0244939. eCollection 2021.

Hepatic Sarcoidosis: An Uncommon Cause of Cirrhosis.

Cureus. 2019 Dec 6;11(12):e6316. doi: 10.7759/cureus.6316.

Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6.

Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.

World J Hepatol. 2019 Jan 27;11(1):1-18. doi: 10.4254/wjh.v11.i1.1.

Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin.

J Cell Biol. 2017 Nov 6;216(11):3799-3816. doi: 10.1083/jcb.201704053. Epub 2017 Oct 11.

Cancer-associated fibroblasts lead tumor invasion through integrin-β3-dependent fibronectin assembly.

J Cell Biol. 2017 Nov 6;216(11):3509-3520. doi: 10.1083/jcb.201702033. Epub 2017 Sep 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma.

Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3190-3191. doi: 10.1007/s00259-023-06324-y. Epub 2023 Jul 5.

AlF-NOTA-FAPI-04 outperforms F-FDG PET/CT in imaging for intrahepatic metastasis of hepatocellular carcinoma.

Hell J Nucl Med. 2022 Sep-Dec;25(3):326-327. doi: 10.1967/s002449912527.

[ Ga]Ga-DOTA-FAPI-04 PET/CT imaging of cirrhosis with hepatocellular carcinoma.

Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1536-1537. doi: 10.1007/s00259-022-06077-0. Epub 2022 Dec 12.

FAPI PET Positivity in Fibrolamellar Hepatocellular Carcinoma.

Clin Nucl Med. 2023 Jul 1;48(7):e332-e333. doi: 10.1097/RLU.0000000000004661. Epub 2023 Apr 17.

Liver metastases from medullary thyroid carcinoma detected on Ga-FAPI-04 PET/CT.

Endocrine. 2021 Dec;74(3):727-728. doi: 10.1007/s12020-021-02800-3. Epub 2021 Jun 24.

Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [F]F-FDG PET/CT in Patients with Liver Malignancies.

Mol Imaging Biol. 2022 Oct;24(5):818-829. doi: 10.1007/s11307-022-01732-2. Epub 2022 Apr 29.

68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient.

Clin Nucl Med. 2020 Oct;45(10):e430-e432. doi: 10.1097/RLU.0000000000003015.

The Added Value of Contrast-Enhanced 68 Ga-FAPI-04 PET/MRI Over 18 F-FDG PET/CT in Hepatocellular Carcinoma.

Clin Nucl Med. 2024 Nov 1;49(11):1039-1040. doi: 10.1097/RLU.0000000000005342. Epub 2024 Jun 20.

Comparison of Baseline Ga-FAPI and F-FDG PET/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib.

J Nucl Med. 2023 Oct;64(10):1532-1539. doi: 10.2967/jnumed.123.265712. Epub 2023 Jul 27.

[Ga]Ga-DOTA-FAPI-04 and [F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with hepatic cancer.

Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2078-2079. doi: 10.1007/s00259-020-04847-2. Epub 2020 May 8.

引用本文的文献

Intriguing information from recent letter and article regarding unwanted targeting of salivary glands by PSMA ligands.

Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):2950-2951. doi: 10.1007/s00259-023-06325-x. Epub 2023 Jul 3.

本文引用的文献

PET Imaging of Hepatocellular Carcinoma Using ZD2-(Ga-NOTA).

J Hepatocell Carcinoma. 2023 Feb 22;10:291-301. doi: 10.2147/JHC.S390939. eCollection 2023.

[ Ga]Ga-DOTA-FAPI-04 PET/CT imaging of cirrhosis with hepatocellular carcinoma.

Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1536-1537. doi: 10.1007/s00259-022-06077-0. Epub 2022 Dec 12.

Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosis: When East meets West.

PLoS One. 2021 Jan 13;16(1):e0244939. doi: 10.1371/journal.pone.0244939. eCollection 2021.

Hepatic Sarcoidosis: An Uncommon Cause of Cirrhosis.

Cureus. 2019 Dec 6;11(12):e6316. doi: 10.7759/cureus.6316.

Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

J Nucl Med. 2019 Jun;60(6):801-805. doi: 10.2967/jnumed.119.227967. Epub 2019 Apr 6.

Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review.

World J Hepatol. 2019 Jan 27;11(1):1-18. doi: 10.4254/wjh.v11.i1.1.

Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin.

J Cell Biol. 2017 Nov 6;216(11):3799-3816. doi: 10.1083/jcb.201704053. Epub 2017 Oct 11.

Cancer-associated fibroblasts lead tumor invasion through integrin-β3-dependent fibronectin assembly.

J Cell Biol. 2017 Nov 6;216(11):3509-3520. doi: 10.1083/jcb.201702033. Epub 2017 Sep 20.

PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献